Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Glenmark Pharmaceuticals Limited

GLENMARK.NS Technical Analysis Summary (NSE)

Analyze GLENMARK.NS on the NSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

GLENMARK.NS●NSE
HealthcareDrug Manufacturers - Specialty & Generic
₹2192.50
₹0.50(0.02%)
Indian Market is Open · 11:51

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

GLENMARK.NS Technical Analysis Summary (NSE)

Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) stock currently shows a neutral trend on the NSE, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 43.50)
Trend Strength:Weak (ADX: 17.28)
Volatility:Medium (ATR: 55.07)
Support/Resistance:$2155.35 – $2323.01 (Bollinger Bands)

Technical conditions suggest Glenmark Pharmaceuticals Limited on the NSE is awaiting a decisive move. Overall, Glenmark Pharmaceuticals Limited remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 43.50

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 19.80

Bullish
Oversold zone signals rebound potential.

Williams %R: -81.26

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -3.04

Bearish
Selling pressure outweighs buying.

Takeaway:Glenmark Pharmaceuticals Limited shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: -4.25

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 17.28

Weak
Weak trend, market trading sideways.

ATR (14): 55.07

Rising
Rising volatility, market activity increasing.

CCI (14): -107.47

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Glenmark Pharmaceuticals Limited shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$2323.01
Middle Band (SMA 20)
$2239.18
Lower Band
$2155.35
Current Position
Within Bands

Takeaway:Glenmark Pharmaceuticals Limited trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$2339.42
Middle Line (EMA 20)
$2229.28
Lower Channel
$2119.15
Squeeze Status
Squeeze On

Takeaway:Glenmark Pharmaceuticals Limited trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume106.85K
Money Flow Index40.65Neutral, balanced money flows with no clear signal.
Relative Vigor Index58.10Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:GLENMARK.NS shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS), here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Technical indicators for Glenmark Pharmaceuticals Limited are mixed, suggesting a Hold or wait-and-see approach.

(NSE: GLENMARK.NS) Technical Analysis FAQ